American Century Companies Inc Crispr Therapeutics Ag Transaction History

American Century Companies Inc

$167 Billion
Q3 2024

A detailed history of American Century Companies Inc transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, American Century Companies Inc holds 18,307 shares of CRSP stock, worth $739,419. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,307

Previous 18,411 0.56%

Holding current value

$739,419

Previous $994,000 13.48%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$44.62 - $62.75 $4,640 - $6,526	-104 Reduced 0.56%	18,307 $860,000
Q2 2024 Aug 07, 2024	BUY	$51.17 - $68.18 $35,972 - $47,930	703 Added 3.97%	18,411 $994,000
Q1 2024 May 14, 2024	BUY	$60.67 - $89.12 $182,920 - $268,696	3,015 Added 20.52%	17,708 $1.21 Million
Q4 2023 Feb 13, 2024	BUY	$38.62 - $72.18 $567,443 - $1.06 Million	14,693 New	14,693 $919,000
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $55,511 - $72,157	1,223 Added 9.78%	13,732 $623,000
Q2 2023 Aug 14, 2023	BUY	$43.47 - $67.77 $32,645 - $50,895	751 Added 6.39%	12,509 $702,000
Q1 2023 May 11, 2023	BUY	$41.0 - $56.12 $52,562 - $71,945	1,282 Added 12.24%	11,758 $531,000
Q4 2022 Feb 13, 2023	BUY	$39.19 - $65.67 $69,052 - $115,710	1,762 Added 20.22%	10,476 $425,000
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $12.3 Million - $16.8 Million	-200,553 Reduced 95.84%	8,714 $570,000
Q2 2022 Aug 12, 2022	BUY	$43.23 - $73.83 $9.05 Million - $15.5 Million	209,267 New	209,267 $12.7 Million
Q1 2022 May 11, 2022	SELL	$53.19 - $79.24 $20 Million - $29.8 Million	-375,854 Closed	0 $0
Q4 2021 Feb 07, 2022	SELL	$70.09 - $111.29 $63,641 - $101,051	-908 Reduced 0.24%	375,854 $28.5 Million
Q3 2021 Nov 10, 2021	SELL	$110.2 - $156.64 $7,714 - $10,964	-70 Reduced 0.02%	376,762 $42.2 Million
Q2 2021 Aug 05, 2021	BUY	$100.84 - $161.89 $9.88 Million - $15.9 Million	98,017 Added 35.15%	376,832 $61 Million
Q1 2021 May 14, 2021	SELL	$110.72 - $210.04 $9.26 Million - $17.6 Million	-83,614 Reduced 23.07%	278,815 $34 Million
Q4 2020 Feb 12, 2021	SELL	$79.67 - $173.23 $25.3 Million - $55.1 Million	-317,991 Reduced 46.73%	362,429 $55.5 Million
Q3 2020 Nov 13, 2020	BUY	$78.5 - $100.64 $15.7 Million - $20.1 Million	199,720 Added 41.55%	680,420 $56.9 Million
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $14 Million - $27.7 Million	364,764 Added 314.63%	480,700 $35.3 Million
Q1 2020 May 14, 2020	BUY	$33.68 - $62.53 $3.9 Million - $7.25 Million	115,936 New	115,936 $4.92 Million

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.15B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Century Companies Inc, based on Form 13F filings with the SEC.

News

Stay updated on American Century Companies Inc with notifications on news.

Account

American Century Companies Inc Crispr Therapeutics Ag Transaction History